Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.8 USD | +5.43% | +5.75% | +20.35% |
May. 09 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
May. 08 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.35% | 468M | |
+23.37% | 47.02B | |
+50.01% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- CCCC Stock
- News C4 Therapeutics, Inc.
- C4 Therapeutics, Inc.(NasdaqGS: CCCC) dropped from Russell 2000 Value Index